Food Supplements Vs Nutraceuticals Under FSSAI: Key Regulatory Differences Brands Must Know In 2025

India’s rapidly expanding health and wellness industry has created enormous opportunities for brands launching vitamins, herbal products, protein formulations, functional beverages, probiotics, and bioactive nutrition products. However, under Indian food law, not all wellness products are regulated the same way.

A turmeric capsule is not automatically a “natural supplement,” and a probiotic drink is not simply a “fortified beverage.” Under the Food Safety and Standards Authority of India (FSSAI), these products may fall into entirely different regulatory categories either as Food Supplements (Health Supplements) or Nutraceuticals.

This distinction is far more than a technical classification exercise. It directly affects:

• Product approval pathways 
• Ingredient eligibility 
• Dosage limits 
• Scientific substantiation requirements 
• Labeling obligations 
• Advertising permissions 
• Market authorization timelines 
• Regulatory enforcement exposure 

Incorrect classification can lead to delayed approvals, product reformulation, label rejection, advertising violations, import detention, or even product bans.

This comprehensive guide by Maven Regulatory Solutions explains the regulatory differences between food supplements and nutraceuticals under FSSAI, highlights major 2025 regulatory developments, and outlines how brands can strategically align product formulation and compliance planning for long-term success.

Understanding The FSSAI Regulatory Framework

Food supplements and nutraceuticals in India are regulated under:

Food Safety and Standards (Health Supplements, Nutraceuticals, Foods for Special Dietary Use, Foods for Special Medical Purpose, Functional Foods and Novel Foods) Regulations, 2016

along with subsequent amendments, advisories, and guidance updates issued through 2025.

FSSAI Product Categories Include

Correct category identification is critical because FSSAI applies distinct compliance obligations to each classification.

What Are Food Supplements Under FSSAI?

Under Indian regulations, food supplements are legally categorized as:

Health Supplements

These products are intended to supplement the normal diet by providing concentrated sources of nutrients or substances with nutritional value.

Regulatory Definition

Food supplements are products designed to:

• Support general nutrition 
• Address dietary deficiencies 
• Provide nutritional maintenance 
• Supplement daily nutrient intake 

Importantly, they must:

Not exert pharmacological, immunological, or therapeutic action.

Common Ingredients Used in Food Supplements

Typical ingredients include:

• Vitamins (A, B-complex, C, D, E) 
• Minerals (Calcium, Zinc, Iron, Magnesium) 
• Amino acids 
• Proteins 
• Essential fatty acids 
• Electrolytes 
• Approved botanical extracts 

Key Regulatory Conditions

Food supplements are generally considered lower-risk products when formulated within approved regulatory limits.

What Are Nutraceuticals Under FSSAI?

Nutraceuticals differ significantly because they are intended to provide:

Functional or Physiological Benefits Beyond Basic Nutrition

These products contain bioactive ingredients capable of influencing physiological or biochemical functions within the body.

Common Nutraceutical Ingredients

Examples include:

• Curcumin 
• Lycopene 
• Omega-3 concentrates 
• Probiotics 
• Prebiotics 
• Polyphenols 
• Flavonoids 
• Plant sterols 
• Antioxidants 
• Bioactive herbal extracts 

Key Regulatory Characteristics

Because nutraceuticals operate closer to the interface between food and science, FSSAI scrutiny is considerably higher.

Scientific Difference Between Food Supplements & Nutraceuticals

Comparative Overview

Food supplements primarily prevent nutrient deficiencies, while nutraceuticals aim to optimize physiological function and reduce health risk without crossing into medicinal territory.

Key Regulatory Differences Under FSSAI Law

1. Licensing & Product Classification

Food Supplements

• Licensed as Health Supplements 
• Simpler approval pathway 
• Lower scientific substantiation burden 

Nutraceuticals

• Require nutraceutical category classification 
• Subject to increased regulatory scrutiny 
• May require additional dossiers for novel ingredients or higher dosages 

Incorrect classification remains one of the most common causes of FSSAI licensing delays.

2. Ingredient Approval & Dosage Limits

Nutraceutical formulations often require significantly stronger scientific justification.

3. Labeling Requirements Under FSSAI

Both categories must comply with core FSSAI labeling requirements, including:

• Product category declaration 
• Ingredient disclosure 
• Recommended usage instructions 
• Serving size 
• Dosage warning statements 
• Mandatory disclaimer: 

“NOT FOR MEDICINAL USE”

Additional Nutraceutical Labeling Requirements

Nutraceuticals may also require:

Label review is increasingly becoming a high-risk regulatory area under FSSAI enforcement.

4. Health Claims & Advertising Restrictions

Food Supplements

Generally permitted claims include:

• “Supports immunity” 
• “Helps maintain bone health” 
• “Supports nutritional wellness” 

Nutraceuticals

More targeted functional claims may be permitted where scientifically substantiated.

However:

Disease treatment, prevention, or cure claims remain strictly prohibited.

FSSAI continues aggressive enforcement against pharmaceutical-style marketing claims.

Major FSSAI Updates In 2025 Brands Must Know

FSSAI has significantly tightened oversight in several areas.

Key 2025 Regulatory Developments

These developments are reshaping formulation, packaging, and market access strategies across the wellness industry.

Why Product Misclassification Creates Major Regulatory Risk

Incorrect classification may result in:

• FSSAI license rejection 
• Product launch delays 
• Mandatory reformulation 
• Label non-compliance notices 
• Advertising restrictions 
• Product withdrawal 
• Import clearance delays 
• Increased enforcement exposure 

Early regulatory assessment substantially reduces commercialization risk.

Strategic Compliance Considerations for Brands

Critical Areas Requiring Attention

Brands should proactively evaluate:

• Ingredient eligibility 
• Dosage justification 
• Scientific substantiation quality 
• Label claim strategy 
• Advertising compliance 
• Packaging disclosures 
• QR code implementation 
• Novel ingredient risk 
• Portfolio harmonization 

Integrated regulatory planning is increasingly essential for long-term market success.

Common Compliance Challenges Under FSSAI

Organizations frequently encounter challenges involving:

• Ambiguous product positioning 
• Excessive dosage levels 
• Unsupported health claims 
• Novel ingredient classification 
• Incomplete scientific substantiation 
• Label formatting errors 
• Inconsistent advertising language 
• Cross-border ingredient differences 

Proactive regulatory strategy significantly reduces approval delays and enforcement risk.

Future Trends in Nutraceutical & Supplement Regulation

Emerging trends include:

• Increased clinical evidence expectations 
• Greater digital traceability requirements 
• Expanded sustainability disclosures 
• AI-enabled compliance monitoring 
• Stronger Nutri vigilance systems 
• Greater alignment with international standards 
• Enhanced consumer transparency initiatives 
• Increased scrutiny of botanical actives 

India’s nutraceutical sector is moving toward increasingly science-driven regulation.

How Maven Regulatory Solutions Supports FSSAI Compliance

Our Services

• Food supplement vs nutraceutical classification 
• Ingredient eligibility assessment 
• Dosage & formulation review 
• Scientific substantiation strategy 
• Label compliance review 
• FSSAI licensing support 
• Regulatory gap assessment 
• Claim substantiation consulting 
• Novel ingredient evaluation 
• End-to-end regulatory strategy 

Why Choose Maven

• Deep FSSAI regulatory expertise 
• Strong nutraceutical compliance experience 
• Science-driven regulatory approach 
• Integrated formulation and compliance support 
• Up-to-date regulatory intelligence 
• Practical commercialization strategies 

Our approach helps brands achieve:

• Faster market access 
• Reduced compliance risk 
• Stronger product positioning 
• Sustainable regulatory alignment 
• Improved commercialization success 

Need Support with FSSAI Food Supplement or Nutraceutical Compliance?

Whether you are classifying a new wellness product, reviewing dosage limits, preparing scientific substantiation, or updating labels for FSSAI compliance, Maven Regulatory Solutions can help simplify your regulatory pathway.

Contact Maven Regulatory Solutions For:

• Product classification support 
• Nutraceutical compliance strategy 
• FSSAI licensing guidance 
• Label review and claim assessment 
• Ingredient eligibility evaluation 
• Scientific substantiation support 
• Novel ingredient strategy 
• End-to-end regulatory consulting 

Visit Maven Regulatory Solutions to connect with our FSSAI regulatory experts today.

Conclusion

Under FSSAI law, the distinction between food supplements and nutraceuticals is not merely semantic, it is strategically critical. Product classification determines the applicable regulatory pathway, scientific evidence burden, claim flexibility, labeling obligations, and overall compliance risk.

As India’s wellness sector continues evolving in 2025, brands that proactively align formulation science with regulatory strategy will be best positioned for sustainable growth and market success.

Maven Regulatory Solutions partners with supplement and nutraceutical brands to deliver scientifically robust, regulatorily compliant, and commercially viable regulatory strategies across the full product lifecycle.

Frequently Asked Questions 

Q1. Can nutraceuticals exceed RDA limits under FSSAI?

Yes. Nutraceuticals may exceed RDA limits if supported by appropriate scientific justification and regulatory acceptance.

Q2. Are herbal products automatically classified as nutraceuticals?

No. Classification depends on ingredient profile, dosage, intended use, and claims.

Q3. Can nutraceuticals claim disease treatment or cure?

No. Therapeutic or curative claims are prohibited under FSSAI regulations.

Q4. Is QR code labeling mandatory for all supplements?

Currently, enhanced QR traceability requirements apply primarily to certain nutraceutical products, particularly higher-value categories.

Q5. What is the difference between a food supplement and a nutraceutical?

Food supplements primarily provide nutritional support, while nutraceuticals deliver scientifically supported physiological or functional benefits.

Q6. Can novel ingredients be used in nutraceuticals?

Yes, but additional safety evaluation and regulatory assessment may be required.

Q7. How can Maven support FSSAI compliance projects?

Maven provides product classification, scientific substantiation, labeling review, licensing support, and complete regulatory strategy services.